Joint Analysis for Multiple Traits by Wang, Zhenchuan
Michigan Technological University 
Digital Commons @ Michigan Tech 
Dissertations, Master's Theses and Master's Reports 
2018 
Joint Analysis for Multiple Traits 
Zhenchuan Wang 
Michigan Technological University, zwang10@mtu.edu 
Copyright 2018 Zhenchuan Wang 
Recommended Citation 
Wang, Zhenchuan, "Joint Analysis for Multiple Traits", Open Access Dissertation, Michigan Technological 
University, 2018. 
https://digitalcommons.mtu.edu/etdr/632 
Follow this and additional works at: https://digitalcommons.mtu.edu/etdr 
 Part of the Statistics and Probability Commons 
JOINT ANALYSIS FOR MULTIPLE TRAITS 
 
 
By 
Zhenchuan Wang 
 
 
 
A DISSERTATION 
Submitted in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
In Mathematical Sciences 
 
MICHIGAN TECHNOLOGICAL UNIVERSITY 
2018 
 
© 2018 Zhenchuan Wang 
  
This dissertation has been approved in partial fulfillment of the requirements for the 
Degree of DOCTOR OF PHILOSOPHY in Mathematical Sciences. 
 
Department of Mathematical Sciences 
  
 Dissertation Co-Advisor: Shuanglin Zhang 
 Dissertation Co-Advisor: Qiuying Sha 
 Committee Member: Kui Zhang 
 Committee Member: Laura E. Brown 
 Department Chair: Mark S. Gockenbach 
 
iii 
Table of Contents  
List of tables………………………………………………………………………………v 
List of figures ..................................................................................................................... vi 
Preface ................................................................................................................................ ix 
Acknowledgements ..............................................................................................................x 
Abstract .............................................................................................................................. xi 
1 Chapter 1: Joint analysis of multiple traits in rare variant association studies ...........1 
1.1 Introduction ......................................................................................................1 
1.2 Methods ............................................................................................................4 
1.3 Comparisons of Tests .......................................................................................5 
1.4 Simulation Study ..............................................................................................7 
1.5 Results ..............................................................................................................9 
1.6 Discussion ......................................................................................................11 
1.7 Tables and Figures ..........................................................................................13 
2 Chapter 2: Joint Analysis of Multiple Traits Using “Optimal” Maximum 
Heritability Test .................................................................................................................18 
2.1 Introduction ....................................................................................................18 
2.2 Methods ..........................................................................................................20 
2.3 Comparison of Methods .................................................................................23 
2.4 Simulation Studies ..........................................................................................24 
2.5 Simulation Results ..........................................................................................25 
2.6 Discussion ......................................................................................................26 
2.7 Tables and Figures ..........................................................................................29 
3 Chapter 3: Testing an optimally weighted combination of common and/or rare 
variants with multiple traits ...............................................................................................33 
3.1 Introduction ....................................................................................................33 
3.2 Methods ..........................................................................................................36 
3.3 Comparison of Methods .................................................................................38 
3.4 Simulations .....................................................................................................40 
3.5 Results ............................................................................................................43 
iv 
3.6 Application to the COPDGene .......................................................................45 
3.7 Discussion ......................................................................................................46 
3.8 Tables and Figures ..........................................................................................47 
4 Reference List ...........................................................................................................52 
Appendix A: Supplementary Tables ..................................................................................59 
Appendix B: Supplementary Figures .................................................................................61 
v 
List of tables 
Table 1.1.  The estimated type I error rates of four methods for quantitative traits under 
variance model 1.. .....................................................…………………………….13 
Table 1.2.  The estimated type I error rates of four methods for qualitative traits under 
variance model 1. ...............................................................………………………14 
Table 2.1.  The estimated type I error rates of MHT and MHT-O. 10,000 replicates are 
used…………………………………………………………………………....…29  
Table 3.1.  The estimated type I error rates of TOWmuT for 10 quantitative traits under 
each model with covariates.. .....………………………………………………….48 
Table 3.2.  The estimated type I error rates of TOWmuT for the mixture of five 
quantitative traits and five qualitative traits under each model with covariates……...….49 
Table 3.3.  Significant blocks identified by at least one method (p-values less than 4×10-
6) and the corresponding p-values in the analysis of COPDGene…………….……...….50 
  
vi 
List of figures 
Figure 1.1.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for quantitative traits under 
variance model 1…….. .........................................................................……….....15 
Figure 1.2.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for 
quantitative traits under variance model 1………….. ..........................………….16 
Figure 1.3.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for 
quantitative traits under variance model 1.………….. ..................………………17 
Figure 2.1.  Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHT-O 
and MANOVA) for the power as a function of the effect size……..……………36 
Figure 2.2.  Power comparisons of the five tests (SUM_ SCORE, TATES, MHT, MHT-O 
and MANOVA) for the power as a function of the effect size……………..……37 
Figure 2.3.  Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHT-O 
and MANOVA) for the power as a function of the effect size…………………..38 
Figure 3.1. Power comparisons of the six tests (Single-TOW, MSKAT, AWRR, 
MANOVA, GAMuT and TOWmuT) for the power as a function of total 
heritability for 10 quantitative traits with covariates ………….. ..................……51 
Figure 3.2. Power comparisons of the five tests (Single-TOW, AWRR, GAMuT, 
MSKAT and TOWmuT) for the power as a function of heritability for the mixture of half 
quantitative traits and half qualitative traits with covariates. ……………………...……52 
 
Figure B.1.1. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for quantitative traits and 
variance model 2 ....................................................................................................77 
Figure B.1.2.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for 
quantitative traits and variance model 2.………….. ............................………….78 
Figure B.1.3.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for 
quantitative traits and variance model 2. ..............................................………….79 
vii 
Figure B.1.4.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for qualitative traits and variance 
model 1.………….................................................................................………….80 
Figure B.1.5.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for 
qualitative traits and variance model 1.………….. .......................………………81 
Figure B.1.6.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for 
qualitative traits and variance model 1.………….. .......................………………82 
Figure B.1.7.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for qualitative traits and variance 
model 2…………...........................................................................………………83 
Figure B.1.8.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for 
qualitative traits and variance model 2.………….. .......................………………84 
Figure B.1.9.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for 
qualitative traits and variance model 2………….. ........................………………85 
Figure B.1.10.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for quantitative traits under 
variance model 1.………….. .........................................................………………86 
Figure B.1.11.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for 
quantitative traits under variance model 1. ………... ............................................87 
Figure B.1.12.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for 
quantitative traits under variance model 1.……… ................................................88 
Figure B.1.13.  Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of LP for quantitative traits under variance 
model 1. ………….............................................................................................…89 
Figure B.2.1.  Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHT-
O and MANOVA) for the power as a function of the effect size (model 1). ...…91 
Figure B.3.1.  Power comparisons of the six tests (Single-TOW, MSKAT, AWRR, 
MANOVA, GAMuT and TOWmuT) for the power as a function of within-factor 
viii 
correlation for models 1-5 and between-factor correlation for model 6 for 10 quantitative 
traits with covariates………………………………………………………………. ...…92 
Figure B.3.2.  Power comparisons of the six tests (Single-TOW, MSKAT, AWRR, 
MANOVA, GAMuT and TOWmuT) for the power as a function of the percentage of 
protective variants for 10 quantitative traits with covariates .………………. ……….…93 
ix 
Preface 
This dissertation is submitted for the degree of Doctor of Philosophy at Michigan 
Technological University. The research described herein was conducted under the 
supervision of Prof. Shuanglin Zhang and Prof. Qiuying Sha in the Department of 
Mathematical Sciences, Michigan Technological University, between September 2013 and 
March 2018.  
This work is to the best of my knowledge original, except where references are made to 
previous work. Part of this work contains previously published material. The title of 
Chapter 1 is Joint analysis of multiple traits in rare variant association studies and it was 
published in the Annals of Human Genetics (Wang, Z., Wang, X., Sha, Q., and Zhang, S., 
2016, 80(3):162-171). The overall study was designed by Shuanglin Zhang. Zhenchuan 
Wang and Shuanglin Zhang conducted the statistical analyses. Zhenchuan Wang, 
Shuanglin Zhang, and Qiuying Sha drafted the manuscript. Chapter 2 entitled Joint 
Analysis of Multiple Traits Using “Optimal” Maximum Heritability Test was published in 
Plos One (Wang, Z., Sha, Q., and Zhang, S. 2016, 11(3): e0150975). Zhenchuan Wang, 
Shuanglin Zhang, and Qiuying Sha developed the methodology and wrote the original 
draft. Zhenchuan Wang and Shuanglin Zhang performed formal analysis. Shuanglin Zhang 
and Qiuying Sha provided comments and review for editing. The title of Chapter 3 is 
Testing an optimally weighted combination of common and/or rare variants with multiple 
traits and it is under review in PLOS ONE (Wang, Z., Sha, Q., Zhang K., and Zhang, S. 
2018). Shuanglin Zhang designed the overall study. Zhenchuan Wang, Shuanglin Zhang, 
and Kui Zhang conducted statistical analyses, and Zhenchuan Wang, Qiuying sha and 
Shaunglin Zhang wrote the manuscript. 
x 
Acknowledgements 
At Michigan Technological University, I have obtained valuable experience in massive 
testing and high-dimensional data and analysis by effective collaborations with scientists 
in statistical genetics and biotechnology. I would like to express my deep appreciations to 
many professionals who helped me broaden my knowledge.  
First of all, I express my sincere gratitude to the committee. I owe a great debt of gratitude 
to Dr. Shuanglin Zhang, who serves as my advisor and deserves my special appreciation 
for his dedicated advising and long-term support. Forever, I am motivated by his 
exponential insights and efforts in statistical genetics. I extend my appreciation to Dr. Sha 
for her important advice and discussions on my research topics, to Dr. Kui Zhang and Dr. 
Laura Brown who carefully examined my dissertation and suggested substantial 
improvements. It is my honor to have these outstanding professors on my committee.  
Many influential graduate students and professors deserve special thanks for their 
collaborations and instructions. I cannot name them all but must thank Dr. Xuexia Wang, 
Huanhuan Zhu, Dr. Xiao Zhang, Dr. Jianping Dong, and Dr. Mark S. Gockenbach.  
xi 
Abstract 
This dissertation includes three papers with each distributed in one chapter.  
In chapter 1, we proposed an Adaptive Weighting Reverse Regression (AWRR) method to 
test association between multiple traits and rare variants in a genomic region. AWRR is 
robust to the directions of effects of causal variants and is also robust to the directions of 
association of traits. Using extensive simulation studies, we compared the performance of 
AWRR with canonical correlation analysis (CCA), Single-TOW, and the Weighted Sum 
Reverse Regression (WSRR). Our results showed that, in all of the simulation scenarios, 
AWRR is consistently more powerful than CCA. In most scenarios, AWRR is more 
powerful than Single-TOW and WSRR. 
In chapter 2, we proposed an “optimal” maximum heritability test (MHT-O) to test the 
association between multiple traits and a single variant. MHT-O includes a procedure of 
deleting traits that have weak or no association with the variant. Using extensive simulation 
studies, we compared the performance of MHT-O with MHT, Trait-based Association Test 
uses Extended Simes procedure (TATES), SUM_SCORE and MANOVA. Our results 
showed that, in all of the simulation scenarios, MHT-O is either the most powerful test or 
comparable to the most powerful test among the five tests we compared.  
In chapter 3, we developed a statistical method by testing an optimally weighted 
combination of variants with multiple traits (TOWmuT) to test the association between 
multiple traits and a weighted combination of variants (rare and/or common) in a genomic 
region. TOWmuT is robust to the directions of effects of causal variants and is applicable 
to different types of traits. Using extensive simulation studies, we compared the 
performance of TOWmuT with the following five existing methods: gene association with 
multiple traits (GAMuT), multiple sequence kernel association test (MSKAT), adaptive 
weighting reverse regression (AWRR), single-TOW, and MANOVA. Our results showed 
that, in all of the simulation scenarios, TOWmuT has correct type I error rates and is 
consistently more powerful than the other five tests. We also illustrated the usefulness of 
TOWmuT by analyzing a whole-genome genotyping data from a lung function study.                  
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1 Chapter 1 
Joint analysis of multiple traits in rare variant association studies 
Abstract: The joint analysis of multiple traits has recently become popular since it can 
increase statistical power to detect genetic variants and there is increasing evidence 
showing that pleiotropy is a widespread phenomenon in complex diseases. Currently, most 
of existing methods for the joint analysis of multiple traits are to test association between 
one common variant and multiple traits. However, the variant-by-variant methods for 
common variant association studies may not be optimal for rare variant association studies 
due to the allelic heterogeneity as well as the extreme rarity of individual variants. Current 
statistical methods for rare variant association studies are for one single trait only. In this 
paper, we propose an Adaptive Weighting Reverse Regression (AWRR) method to test 
association between multiple traits and rare variants in a genomic region. AWRR is robust 
to the directions of effects of causal variants and is also robust to the directions of 
association of traits. Using extensive simulation studies, we compare the performance of 
AWRR with canonical correlation analysis (CCA), Single-TOW, and the Weighted Sum 
Reverse Regression (WSRR). Our results show that, in all of the simulation scenarios, 
AWRR is consistently more powerful than CCA. In most scenarios, AWRR is more 
powerful than Single-TOW and WSRR.  
Introduction 
There is increasing evidence showing that pleiotropy, the effect of one variant on multiple 
traits, is a widespread phenomenon in complex diseases [Sivakumaran et al., 2011]. 
Furthermore, in genetic association studies of complex diseases, multiple related traits are 
usually measured. For example, hypertension is evaluated using systolic and diastolic 
blood pressures, the Metabolic Syndrome is based on observing three of five criteria [Sattar 
et al., 2008], and neuropsychiatric disorders depend on a range of overlapping clinical 
characteristics[O'Reilly et al., 2012]. Although most published genome-wide association 
studies (GWAS) analyze each of the related traits separately, the joint analysis of multiple 
traits not only can increase statistical power to detect genetic variants [Solovieff et al., 
2013; Stephens, 2013; Yang & Wang, 2012; Zhou & Stephens, 2014], but also can be 
crucial to understand the genetic architecture of the disease of interest [Aschard et al., 
2014]. Thus, the joint analysis of multiple traits has recently become popular. Several 
statistical methods for the joint analysis of multiple traits have been developed. These 
methods can be roughly divided into three groups: regression methods, combining test 
statistics from univariate analysis, and dimension reduction methods. Regression methods 
include mixed effects models [Korte et al., 2012; Zhou & Stephens, 2014] and reverse 
regression models [O'Reilly et al., 2012; Yan et al., 2013]. By modeling the covariance 
structure of correlated traits and dependence structure between individuals, mixed effects 
models not only can incorporate multiple correlated traits, but also can be robust to 
population stratification. Reverse regression models consider genotypes as the response 
variable and all the traits as independent variables, therefore, reverse regression models do 
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not need to know the complex distributions of the traits and can be applied to a large 
number of mixed types of traits. For combining the test statistics from univariate analysis, 
one first obtains univariate test statistics by performing association tests for each trait 
individually and then combines the univariate test statistics by linear combinations 
[O'Brien, 1984; van der Sluis et al., 2013; Yang et al., 2010]. The dimension reduction 
methods include canonical correlation analysis (CCA) [Tang & Ferreira, 2012], principal 
components of traits (PCT) [Aschard et al., 2014], and principal components of heritability 
(PCH) [Klei et al., 2008; Lange et al., 2004; Ott & Rabinowitz, 1999]. CCA is to find a 
linear combination of traits and a linear combination of genotypes at multiple variants such 
that the correlation between the two linear combinations reaches its maximum. PCT is the 
principal component analysis to the traits. The PCT methods are usually based on the first 
PC or first few PCs of the traits [Feng et al., 2007; Klei et al., 2008]. Aschard et al. (2014) 
showed that contrary to the widespread practice, tests based on only the first few PCs often 
have low power, whereas combining signals across all PCs can have greater power. PCH 
is to find a linear combination of multiple traits such that this linear combination has the 
maximum heritability.  
Almost all of the aforementioned methods are to test association between one 
common variant and multiple traits. However, the variant-by-variant methods for common 
variant association studies may not be optimal for rare variant association studies due to 
the allelic heterogeneity as well as the extreme rarity of individual variants [Li & Leal, 
2008]. Recent studies show that complex diseases are caused by both common and rare 
variants [Bodmer & Bonilla, 2008; Kang et al., 2010; Pritchard, 2001; Pritchard & Cox, 
2002; Stratton & Rahman, 2008; Teer & Mullikin, 2010; Walsh & King, 2007]. Next-
generation sequencing technology allows sequencing of the whole genome of large groups 
of individuals, and thus makes rare variant association studies feasible [Andres et al., 2007; 
Metzker, 2010]. Recently, statistical methods for rare variant association studies with a 
single trait have been developed by summarizing genotype information from multiple 
variants. These methods include burden tests [Li & Leal, 2008; Madsen & Browning, 2009; 
Morgenthaler & Thilly, 2007; Price et al., 2010; Zawistowski et al., 2010], quadratic tests 
[Neale et al., 2011; Sha et al., 2012; Wu et al., 2011], and combined tests [Derkach et al., 
2013; Lee et al., 2012; Sha & Zhang, 2014]. Burden tests collapse rare variants in a 
genomic region into a single burden variable and then regress the trait on the burden 
variable to test for the cumulative effects of rare variants in the region. These tests 
implicitly assume that all rare variants are causal and that the directions of the effects are 
all the same. Quadratic tests include tests with statistics of quadratic form of score vector, 
as well as adaptive weighting methods. These tests are robust to the directions of the effects 
of causal variants and are less affected by neutral variants than burden tests. Burden tests 
can only outperform quadratic tests when most of rare variants are causal and the directions 
of the effects of causal variants are all the same. Combined tests combine information from 
burden tests, quadratic tests, and possibly other tests aiming to have advantages of multiple 
tests. 
In this article, we propose an adaptive weighting reverse regression (AWRR) 
method to test association between multiple traits and rare variants in a genomic region. In 
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AWRR, we first propose adaptive weights to collapse genotypes. Then, we use the score 
test to test association based on the reverse regression, in which collapsed genotypes is 
treated as the response variable and multiple traits are treated as independent variables. 
Using extensive simulation studies, we compare the performance of AWRR with CCA, 
Single-TOW, and the Weighted Sum Reverse Regression (WSRR). In the Single-TOW, 
we first calculate the TOW statistic [Sha et al., 2012] to test the association between each 
trait and variants in a genomic region and then the statistic of Single-TOW is the largest of 
TOW statistics. In the WSRR, we first calculate the weighted sum [Madsen & Browning, 
2009] of genotypes at variants in a genomic region and then the statistic of WSRR is the 
score test statistic under reverse regression model, in which the weighted sum of genotypes 
is the response variable and traits are predictor variables. Our results show that, in all of 
the simulation scenarios, AWRR is consistently more powerful than CCA. In most 
scenarios, AWRR is more powerful than Single-TOW and WSRR. 
  
4 
 
Methods 
We consider a sample with n  unrelated individuals. Each individual has K  (potentially 
correlated) traits and has been genotyped at M  variants in a genomic region. Let iky  
denote the thk  trait value of the thi  individual. Let imx  denote the genotype score of the thm  
variant of the thi  individual, where imx  is the number of minor alleles of the thi  individual 
carried at the thm  variant. We denote ( )1, ,
T
i i iKY y y= …  as the K  traits for the thi  
individual. We propose an adaptive weighting reverse regression (AWRR) method to test 
the null hypothesis 0 :H  none of the K  traits are associated with the M  variants in the 
genomic region. For constructing the test statistic of AWRR, we first collapse the M
dimensional genotype ( )1, , Mi ix x…  into a one dimensional number
1
M
i m im
m
x w x
=
= ∑ , where mw  
is the adaptive weight for the thm  variant. The adaptive weight mw  should satisfy properties 
that mw  should be large if the thm  variant has strong association with the K  traits and mw  
should have different signs for risk and protective variants. Then, the statistic of AWRR is 
the score test statistic under the reverse regression model 0
1
K
i k ik i
k
x yβ β ε
=
= + +∑ . In details, 
the AWRR method has the following steps. 
 
1. We define a weight mW  for the thm  variant such that mW  will be large if the thm  
variant has strong association with the K  traits and mW  will be also large if the thm  
variant is a rare variant. For these purposes, we propose 
( )
1
1m mm mp
TW
p
=
−
, 
where mp  is the minor allele frequency of the thm  variant and mT  is the score 
statistic to test the null hypothesis 𝐻𝐻0:𝛽𝛽1 = ⋯ = 𝛽𝛽𝐾𝐾 = 0  under the reverse 
regression model 0 1 1log1
im
i K iK
im
p y y
p
β β β+= + +
−
, where we assume a dominant 
model ( ) ( )Pr 1 Pr 2im im imp x x= = = = . In fact, for rare variants, imx  essentially is 0 or 
1. The score statistic is given by 1Tm m m mT U V U−= , where ( )
1
n
m i im m
i
U xY x
=
= −∑  and 
( ) ( )( )2
1 1
1 n n T
m im m i i
i i
V x Yx Y Y
n
Y
= =
= − −−∑ ∑ , where 
1
1 ,
n
m im
i
x x
n =
= ∑  and 
1
1 .
n
i
i
Y Y
n =
= ∑  Under 
the null hypothesis, mT  follows a 2χ  distribution with degrees of freedom K . 
However, mW  does not consider the direction of the effects of causal variants. 
2. In this step, we will define a direction of mW . We first select a trait (the selected 
trait denoted as the  𝑘𝑘�th trait). We use 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠�𝜌𝜌(𝑦𝑦𝑘𝑘� , 𝑥𝑥𝑚𝑚)� to denote the direction of 
the associations of the thm  variant, where 𝑦𝑦𝑘𝑘� = (𝑦𝑦1𝑘𝑘� , … , 𝑦𝑦𝑛𝑛𝑘𝑘� )  and 
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( )1 , ,
T
m m nmx xx …= .  If the  𝑘𝑘� th trait has no association with the M  variants, the 
directions of the association will be random. In order to try to avoid random 
directions, we propose to choose the trait that has the strongest association with the 
M  variants. Let kTOWT  denote the statistic of TOW [Sha et al., 2012] to test 
association between the thk  trait and the M  variants. kTOWT  is defined as 
1
( )( )
n
k o o
TOW ik k i
i
T y xxy
=
− −= ∑ , where 1
M oo
i m imm
x w x
=
= ∑  and 
2
1 1
( )( ) / ( )n nOm ik im m im mi k iw y y x x x x= == − − −∑ ∑ . We choose the  𝑘𝑘� th trait such that 
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇
𝑘𝑘� = 𝑚𝑚𝑚𝑚𝑥𝑥
1≤𝑘𝑘≤𝐾𝐾
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇
𝑘𝑘 .  
3. The final weight for the thm  variant is given by ( )( )sign ,km m myw x Wρ= % . Let 
1
M
i m im
m
x w x
=
= ∑ . Then, we consider the reverse regression model 0
1
K
i k ik i
k
x yβ β ε
=
= + +∑ . 
We apply a score test to test the null hypothesis 𝐻𝐻0:𝛽𝛽1 = ⋯ = 𝛽𝛽𝐾𝐾 = 0. The score 
statistic is given by 1TAWRRT u V u−= , where ( )
1
n
i i
i
u x Yx
=
= −∑ , 
( ) ( )( )2
1 1
1 n n T
i i i
i i
V x
n
x Y Y YY
= =
= −− −∑ ∑ , 
1
1 ,
n
i
i
x x
n =
= ∑  and 
1
1 .
n
i
i
YY
n =
= ∑  
4. In this step, we evaluate the p-value of AWRRT . Since mw  depends on the trait values 
and the genotype scores, AWRRT  does not follow a 2χ  distribution with degrees of 
freedom K . We use a permutation procedure to evaluate the p-value of AWRRT . In 
each permutation, we randomly shuffle 1 ,, nY Y…  and keep the genotypes of each 
individual unchanged. We repeat step 1 to step 3 based on each permutated data. 
Let 0AWRRT  denote the test statistic of AWRRT  based on the original data and perAWRRT  
denote the test statistic based on the permuted data. Then the p-value of the test 
AWRRT  is the proportion of the number of permutations with 0perAWRR AWRRT T≥ . 
 
Comparisons of Tests 
We compare the performance of the proposed test AWRR with those of the canonical 
correlation analysis (CCA) [Tang & Ferreira, 2012], the Single-TOW method [Sha et al., 
2012], and the Weighted Sum Reverse Regression (WSRR) method [Madsen & Browning, 
2009]. 
CCA method: although the asymptotical distribution of the CCA statistic works 
well for common variants, it is very conservative for rare variants. Thus, we propose to use 
a permutation procedure to evaluate the p-value of the CCA statistic. 
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Single-TOW method: let kTOWT  denote the statistic of TOW [Sha et al., 2012] to 
test association between the thk  trait and the M  variants. The statistic of Single-TOW is 
given by 1max kSingle TOW k K TOWT T− ≤ ≤= . The p-value of Single TOWT −  is evaluated by a permutation 
procedure. 
WSRR method: let 
1
M
i m im
m
X w x
=
= ∑ , where (1 )1m m mpw p= −  and mp  is the minor 
allele frequency of the thm  variant. We consider the reverse regression model 
0
1
K
i k ik i
k
X yβ β ε
=
= + +∑ . The statistic of WSRR, WSRRT , is the score test statistic to test the null 
hypothesis 0 1: 0KH β β= = =L . Under the null hypothesis, WSRRT follows a 2χ   distribution 
with degrees of freedom K .  
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Simulation Study 
Our simulations follow that of Sha et al. (2012). In details, the empirical Mini-Exome 
genotype data provided by the genetic analysis workshop 17 (GAW17) is used for 
simulation studies. This dataset contains genotypes of 697 unrelated individuals on 3205 
genes. We will conduct two sets of simulations.  In the first set of simulations, we choose 
four genes: ELAVL4, MSH4, PDE4B, and ADAMTS4 with 10, 20, 30, and 40 variants, 
respectively. We merge the four genes to form a super gene (Sgene1) with 100 variants 
[Sha et al., 2012]. In the second set of simulations, we choose ten genes: ELAVL4, 
FAM73A, PSMB4, FSHR, GMCL1, HNMT, GALNT13, NEUROD1, MYEOV2, and 
TWF2 with 10 variants in each of them. We merge the ten genes to form a super gene 
(Sgene2) with 100 variants. In our simulation studies, we generate genotypes based on the 
genotypes of 697 individuals in the Sgene1 and Sgene2. To generate a qualitative disease 
affection status, we use a liability threshold model based on a quantitative trait. For a 
qualitative trait, an individual is defined to be affected if the individual’s corresponding 
quantitative trait is at least one standard deviation larger than the phenotypic mean. This 
yields a prevalence of 16% for the simulated disease in the general population. In the 
following, we describe how to generate a quantitative trait. 
To evaluate the type I error, we generate K  traits of an individual independent of 
the genotypes by using  
( )1, 1,
T
KY y uy ρ ρε= … Β −= + , 
where ( ) ( )1, 0,, ~u
T
nu uu MVN I…=  is a vector of un  independent standard normal latent 
variables, ( ) ( )1 ,, ~ 0,
T
K MVN Iε ε ε= …  is a vector of errors, Β  is a uK n×  loading matrix, 
the values of un  and Β  are based on two variance models: (1) 1un = , ( )1, ,1
TΒ = …  and (2) 
2un = , 
[ ]
[ ]
2
2
0
0
K
K K
e
e −
 
Β =  
  
. Thus, ( )~ 0,Y MVN Σ , where ( )1T Iρ ρΣ = ΒΒ + − .  
To evaluate power, we consider that all causal variants are rare (MAF<0.01). We 
randomly choose cn  rare variants as causal variants, where cn  is determined by the 
percentage of causal variants among rare variants. Denote rn  and pn  as the number of risk 
rare variants and protective rare variants, respectively, where r p cn n n+ = . Let 
r
qix  and pjix  
denote the genotypic scores of the thq  risk rare variant and the thj  protective rare variant 
for the thi  individual, respectively. Suppose that causal variants have impact on the L  traits 
among the K  traits and, among the L  traits, there are pL  traits positively correlated with 
risk variants and there are nL  traits negatively correlated with risk variants. Let h  denote 
the heritability of all the cn  rare causal variants on each of the L  traits. Generate cn  
random numbers 1 ,, cnr r…  from an uniform distribution between 0 and 1. The heritability 
8 
 
of the thi  causal variant is given by 
1
c
j
n
i i
j
h hr r
=
= ∑ . Under this assumption, we simulated K  
traits by  
1 1
1 1
1
,
,
, 1
pr
pr
n
r r p p
kq qi kj ji i
n
k p
q j
n
r r p p
ik kq qi kj ji ik p
q j
n
ik
x x
y
k
x x L
L
L
k L
Kk
β β ε
β β ε
ε
= =
= =

− +

= − + +

 <


≤ ≤
 
− ≤ ≤


 
≤
∑ ∑
∑ ∑ , 
where ( )1, ,
T
i i iKε ε ε= …  can be generated in the same way as generating traits of evaluating 
type I error, rkqβ  and pkjβ  are constants and their values depend on the heritability. 
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Results 
For type I error evaluation, we only consider the first set of simulations, but consider 
different sample sizes, different significance levels, different variance models and different 
types of traits. In each simulation scenario, the p-values of AWRR, Single-TOW and CCA 
are estimated by 10,000 permutations (the p-values of WSRR are estimated by a 2χ  
distribution) and the type I error rates of all of the four tests are evaluated using 10,000 
replicated samples. For 10,000 replicated samples, the 95% confidence intervals (CIs) for 
the type I error rates at the nominal levels 0.05 and 0.01 are (0.046, 0.054) and (0.008, 
0.012), respectively.  The estimated type I error rates of the four tests are summarized in 
Tables 1.2, 2.2, A.1.1 and A.1.2. From these tables, we can see that only two estimated 
type I error rates of CCA are not within the CIs and these two type I error rates (one is 
0.0126 for nominal level 0.01 in Table 1.1, and the other one is 0.05505 for nominal level 
0.05 in Table S1) are very close to the upper bounds of the corresponding CIs, which 
indicates that the four tests are all valid. 
For power comparisons, we consider 10 traits and we assume that all causal variants 
are rare. For each type of traits and each variance model, we consider different values of 
heritability, different percentages of protective variants, and different percentages of causal 
variants. In each of the simulation scenarios, the p-values of AWRR, Single-TOW and 
CCA are estimated using 1,000 permutations (the p-values of WSRR are estimated by a 
2χ  distribution) and the power of all of the four tests is evaluated using 500 replicated 
samples at a significance level of 0.05. 
We first consider the first set of simulations for quantitative traits under variance 
model 1. Figure 1.1 provides the power comparisons of the four tests (WSRR, AWRR, 
CCA and Single-TOW) for the power as a function of heritability. This figure shows that 
WSRR is the least powerful one and AWRR is the most powerful one. It is little 
complicated to compare the power of Single-TOW with the power of CCA. When 
genotypes impact on only one trait, Single-TOW is more powerful than CCA; otherwise, 
CCA is more powerful than Single-TOW. Since Single-TOW only depends on the trait that 
has the strongest association with genotypes, it is more favorable for Single-TOW when 
genotypes impact on less traits. Power comparisons of the four tests for the power as a 
function of percentage of protective variants are given by Figure 1.2. This figure shows 
that, with the increasing of the percentage of protective variants, the power of WSRR 
decreases while the power of the other three methods does not change. Other patterns of 
the power comparisons are similar to those shown in Figure 1.1. The power comparisons 
of the four tests for the power as a function of the percentage of causal variants are given 
by Figure 1.3. As shown in this figure, with the increasing of the percentage of causal 
variants, the power of WSRR increases while the power of the other three methods does 
not change. WSRR is the least powerful one when the percentage of causal variants is small 
(≤ 0.15), while WSRR is the most powerful test when the percentage of causal variants is 
large (≥ 0.3). The patterns of the power comparisons of CCA, AWRR and Single-TOW are 
similar to those shown in Figure 1.1.  
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Under the first set of simulations, we also compare the powers of the four methods 
for quantitative traits under variance model 2 and for qualitative traits under variance 
models 1 and 2. These results are given in Figures B.1.1-B.1.9. For each type of traits, the 
patterns of the power comparisons are similar under variance models 1 and 2.  For 
qualitative traits, CCA is consistently less powerful than Single-TOW and AWRR because 
CCA is designed for quantitative traits. For qualitative traits, the powers of AWRR, Single-
TOW, and CCA decrease with the increase of the percentage of protective variants, 
although decrease not as fast as that of WSRR. As pointed out by Wu et al. (2011) and Sha 
et al. (2012), the decrease in the powers of AWRR, Single-TOW, and CCA in the presence 
of both risk and protective variants is due to the fact that protective variants lower MAFs 
in cases and thus make observing rare variants in the cases more difficult. The larger 
decrease in power of WSRR is additionally driven by the sensitivity to the direction of the 
effect due to aggregation of genotypes. 
Under the second set of simulations, we compare the powers of the four methods 
for quantitative traits under variance model 1. Results are given in Figures S10-S12. 
Comparing Figures B.1.10-B.1.12 with Figures 1.1-1.3, the patterns of the power 
comparisons under the second set of simulations are very similar to that under the first set 
of simulations. Under the second set of simulations, we also compare the powers of the 
four methods for quantitative traits under variance model 2 and for qualitative traits under 
variance models 1 and 2 (results are not shown). Results also show that the patterns of the 
power comparisons under the second set of simulations are very similar to that under the 
first set of simulations. 
In summary, for all simulation scenarios, AWRR is consistently more powerful than 
CCA and the power of WSRR increases with the increasing of the percentage of causal 
variants or with the decreasing of the percentage of protective variants. For quantitative 
traits, the powers of AWRR, CCA and Single-TOW are robust to the percentage of 
protective variants and to the percentage of causal variants, while for qualitative traits, the 
powers of AWRR, CCA and Single-TOW decrease with the increasing of the percentage 
of protective variants and are relatively robust to the percentage of causal variants. 
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Discussion 
In this article, we proposed the AWRR method to perform joint analysis of multiple traits 
in rare variant association studies based on the following reasons: (1) the development of 
next-generation sequencing technology has made directly testing all rare variants feasible 
and (2) there is increasing evidence showing that pleiotropy is a widespread phenomenon 
in complex diseases and multiple related traits are usually measured in genetic association 
studies of complex diseases. We used extensive simulation studies to compare the 
performance of AWRR with CCA, WSRR and Single-TOW. Our results showed that 
AWRR has correct type I error rates, is robust to the directions of the association of causal 
variants for quantitative traits, and is robust to the percentage of causal variants. AWRR is 
consistently more powerful than CCA. AWRR is more powerful than Single-TOW and 
WSRR in most simulation scenarios. 
Our simulation studies showed that the performance of each of AWRR, WSRR and 
Single-TOW depends strongly upon the number of traits impacted by genetic variants, the 
percentage of protective variants, and the percentage of causal variants. And no method 
demonstrates consistently good power. To increase the robustness of the test, we can 
combine AWRR, WSRR and Single-TOW aiming to have advantages of the three methods. 
Let AWRRp , WSRRp  and Single TOWp −  denote the p-values of AWRR, WSRR, and Single-TOW, 
respectively. The combined test statistic can be defined as 
{ }min , ,combined AWRR WSRR Single TOWT p p p −= .  However, the performance of the combined test 
needs further investigations.  
In association studies based on unrelated individuals, it has been long recognized 
that population stratification can seriously confound association results [Knowler et al., 
1988; Lander & Schork, 1994]. Several methods have been developed to control for 
population stratification for association studies based on unrelated individuals. These 
methods include GC approach [Devlin & Roeder, 1999; Devlin et al., 2001; Reich & 
Goldstein, 2001], PC approach [Bauchet et al., 2007; Chen et al., 2003; Price et al., 2006; 
Zhang et al., 2003; Zhu et al., 2002], and MLM approach [Kang et al., 2010; Zhang et al., 
2010]. Like most association tests based on unrelated individuals, AWRR subjects to bias 
due to population stratification. To make AWRR robust to population stratification, we can 
use the PC approach. Let ( )1, ,
T
i i iLP p p= …  denote the first L   PCs of the genotypes at a set 
of genomic markers for the thi  individual. In step 3 of AWRR, we can use the residuals of 
the regression Ti i ix Pα β ε+= +  to replace ix  and use the residuals of the regression 
T
ik k k i ikPy α β ε+= +  to replace iky . The performance of using the PC approach to control for 
population stratification in AWRR also needs further investigations. 
The computation time required for running AWRR depends on the sample size, the 
number of variants in the genomic region, the number of traits, and the number of 
permutations. The running time of AWRR with 1000 permutations on the data set with 
1000 individuals, 10 traits, and 100 variants in the genomic region on a laptop with 4 Intel 
12 
 
Cores @ 2.00GHz and 4 GB memory is no more than 0.5s. To perform genome-wide 
studies, we can first select genomic regions that show evidence of association based on a 
small number of permutations (e.g. 1,000), and then a large number of permutations are 
used to test the selected regions. 
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Tables and Figures 
 
Table 1.1. The estimated type I error rates of four methods for quantitative traits under 
variance model 1. 10,000 replicates are used. This set of simulations is based on Sgene1.  
 
 
Sample size 
 500 1000 2000 
𝛼𝛼 = 0.05 
CCA 0.0518 0.0519 0.04645 
Single-TOW 0.04995 0.05255 0.0506 
WSRR 0.0464 0.0506 0.0496 
AWRR 0.0519 0.0527 0.0531 
𝛼𝛼 = 0.01 
CCA 0.012 0.00845 0.0126 
Single-TOW 0.0117 0.00965 0.012 
WSRR 0.0081 0.009 0.0097 
AWRR 0.01075 0.0097 0.01135 
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Table 1.2. The estimated type I error rates of four methods for qualitative traits under 
variance model 1. 10,000 replicates are used. This set of simulations is based on Sgene1.  
 
 
Sample size 
 500 1000 2000 
𝛼𝛼 = 0.05 
CCA 0.052 0.0527 0.04985 
Single-TOW 0.0519 0.0534 0.05 
WSRR 0.0502 0.0493 0.0487 
AWRR 0.054 0.0505 0.05265 
𝛼𝛼 = 0.01 
CCA 0.0101 0.01115 0.00955 
Single-TOW 0.0109 0.01165 0.01115 
WSRR 0.0106 0.0092 0.0106 
AWRR 0.00955 0.00965 0.012 
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Figure 1.1. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-TOW) 
for the power as a function of heritability for quantitative traits under variance model 1. 
The sample size is 1000 and 0.5ρ = . The percentage of the causal variants is 0.1. All causal 
variants are risk variants. The total number of traits is 10. This set of simulations is based 
on Sgene1.  
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Figure 1.2. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-TOW) 
for the power as a function of percentage of protective variants for quantitative traits under 
variance model 1. The sample size is 1000, the percentage of causal variants is 0.2, the 
total heritability is 0.03, and 0.5ρ = . The total number of traits is 10. This set of 
simulations is based on Sgene1. 
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Figure 1.3. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-TOW) 
for the power as a function of the percentage of causal variants for quantitative traits under 
variance model 1. The sample size is 1000 and 0.5ρ = , and the total heritability is 0.03. 
All causal variants are risk variants. The total number of traits is 10. This set of simulations 
is based on Sgene1. 
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2 Chapter 2 
Joint Analysis of Multiple Traits Using “Optimal” Maximum Heritability Test 
Abstract: The joint analysis of multiple traits has recently become popular since it can 
increase statistical power to detect genetic variants and there is increasing evidence 
showing that pleiotropy is a widespread phenomenon in complex diseases. Currently, most 
of existing methods use all of the traits for testing the association between multiple traits 
and a single variant. However, those methods for association studies may lose power in the 
presence of a large number of noise traits. In this paper, we propose an “optimal” maximum 
heritability test (MHT-O) to test the association between multiple traits and a single variant. 
MHT-O includes a procedure of deleting traits that have weak or no association with the 
variant. Using extensive simulation studies, we compare the performance of MHT-O with 
MHT, Trait-based Association Test uses Extended Simes procedure (TATES), 
SUM_SCORE and MANOVA. Our results show that, in all of the simulation scenarios, 
MHT-O is either the most powerful test or comparable to the most powerful test among 
the five tests we compared.  
Introduction 
 
Increasing evidence shows that pleiotropy, the effect of one variant on multiple traits, is a 
widespread phenomenon in complex diseases [Sivakumaran et al., 2011]. Furthermore, in 
genetic association studies of complex diseases, multiple related traits are usually 
measured. For example, hyperuricemia is usually present in patients with gout [Yang et al., 
2010]; coronary heart disease is predicted by cytokine interleukin-6, C-reactive protein, 
interleukin-1, tumor necrosis factor-α and fibrinogen [Yudkin et al., 2000; Rifai and 
Ridker, 2002]; and neuropsychiatric disorders depend on a range of overlapping clinical 
characteristics [O'Reilly et al., 2012]. Although most published genome-wide association 
studies (GWASs) analyze each of the related traits separately, joint analysis of multiple 
traits may increase statistical power to detect genetic variants [Yang and Wang, 2012; 
Solovieff et al., 2013; Stephens, 2013; Zhou and Stephens, 2014]. Thus, joint analysis of 
multiple traits has recently become popular.  
Several statistical methods have been developed for joint analysis of multiple traits. 
These methods can be roughly divided into three groups: combining the univariate analysis 
results, regression methods, and dimension reduction methods. For combining univariate 
analysis results, one first conducts the univariate test by performing an association test for 
each trait individually and then combines the univariate test statistics or combines the p-
values of the univariate tests [O'Brien, 1984; Yang et al., 2010; van der Sluis et al., 2013; 
Kim et al., 2015]. Regression methods include mixed effect models [Korte et al., 2012; 
Zhou and Stephens, 2014; Casale et al., 2015], generalized estimating equation (GEE) 
methods [Zeger and Liang, 1986; Zhang et al., 2014], and reverse regression methods 
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[O'Reilly et al., 2012; Yan et al., 2013]. Mixed effect models can account for relatedness, 
population structure, and polygenic background effect, but it is computationally 
challenging. The GEE methods, based on a marginal regression model, allow the variant 
having different effect sizes and effect directions on different traits. These methods can 
also accommodate covariates and different types of traits. Reverse regression methods take 
genotypes as the response variable and multiple traits as independent predictors, therefore, 
reverse regression models do not need to know the complex distributions of traits and can 
be applied to a large number of mixed types of traits. Dimension reduction methods include 
canonical correlation analysis (CCA) [Tang and Ferreira, 2012], principal components of 
traits (PCT) [Aschard et al., 2014], and principal components of heritability (PCH) [Ott 
and Rabinowitz, 1999; Lange et al., 2004; Klei et al., 2008; Zhou et al., 2015]. CCA is to 
seek a linear combination of multiple variants and a linear combination of multiple traits 
such that the correlation between the two linear combinations reaches its maximum. The 
PCT methods are usually based on the first PC or first few PCs of the traits [Feng et al., 
2007; Klei et al., 2008]. However, as Aschard et al. [2014] showed that testing only the 
first few PCs often has low power, whereas combining signals across all PCs can have 
greater power. Nevertheless, it is not clear how many PCs are needed, and how robust these 
methods are when there exists noise traits. PCH is to find a linear combination of multiple 
traits such that this linear combination has the maximum heritability. 
In this article, we first propose a maximum heritability test (MHT). Based on MHT, 
we develop an “optimal” maximum heritability test (MHT-O) to test the association 
between multiple traits and a single variant. In each step of MHT-O, we delete one trait 
that has the weakest association with the variant. Then, we find the optimal number of traits 
and use MHT to test the association between the optimal number of traits and the variant. 
Using extensive simulation studies, we compare the performance of MHT-O with MHT, 
Trait-based Association Test uses Extended Simes procedure (TATES) [van der Sluis et 
al., 2013], SUM_SCORE and MANOVA [Yang and Wang, 2012]. Our results show that, 
in all of the simulation scenarios, MHT-O is either the most powerful test or comparable 
to the most powerful test among the five tests we compared.  
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Methods 
We consider a sample with n  unrelated individuals. Each individual has K  (potentially 
correlated) traits and has been genotyped at one variant. Let ( )1, ,
T
KY Y Y= … denote the 
random vector of K  traits and X  denote the random variable of the genotype score at a 
variant. Let ( )1, ,
T
i i iKy y y= …  denote the values of K  traits and ix  denote the genotype 
score of the thi  individual, where ix  is the number of minor alleles that the thi  individual 
has at the variant. We can consider that 1 ,, ny y…  is a random sample from Y  and 1 ,, nx x…  
is a random sample from X . 
Now, let us consider linear models 
k k k kY Xα β ε+= +  ( , ,1k K= … ).                                             (1) 
We partition the total phenotypic covariance of Y  as GP RV V V= +  [Falconer and Mackay, 
1996]; [ ] ( )1var , var, TG KV X X Xβ β ββ= =… is the genetic variance due to the genotype 
scores X , where ( )1, ,
T
Kβ β β= … ; [ ]1var , ,R KV ε ε…=  is the residual covariance after 
removing the genetic effect. ( )var X  can be estimated by ( )2
1
1 n
i
i
x x
n =
−∑ , 
1
1 n
i
i
x x
n =
= ∑ .  β  
and RV  can be estimated from the linear models  
ik k k i iky xα β ε+= +  ( , ,1k K= … ; , ,1i n= … ). 
kβ  is estimated by the least square estimator. Let ikr  denote the estimates of residuals ikε . 
Then, the ( )j,k th  element of RV  is estimated by 
1
1
i
n
ij
i
kr rn =
∑ .  
Let us consider a linear combination of 
1
,  
K
T
k
k
kY w Y w Y
=
= ∑ , where ( )1, , TKw w w= … .  
The heritability of Tw Y  can be written as 
2
T
G
P
w T
w V wh
w V w
= .  
If we define 1 2PW V w= ,  we can write 2wh  as  
1
2 2
2
1
T T
P G P
w T T
W V V V W W VWh
W W W W
− −
== , 
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where 2
1
2
1
P G PV V V V
− −
= . The heritability of Tw Y  depends on w  and we can find a linear 
combination of Tw Y  that has the largest heritability among all linear combinations of Y . 
We define the maximum heritability as the test statistic to test the association between these 
K  traits and the variant. We denote this test as maximum heritability test (MHT). The 
MHT statistic can be written as 
( ) ( ) ( ) ( )2 1 1 1max var varT Tw ma aMHT x G Pw m x P PT h V V X V X Vλ λ ββ β β− − −= = = = ,                
where ( )max Aλ  denotes the largest eigenvalue of matrix A . 
However, the test statistic MHTT  may lose power in the presence of a large number 
of noise traits. Therefore, we propose an “optimal” maximum heritability test (MHT-O) to 
test the association between multiple traits and the variant. MHT-O includes a procedure 
of deleting traits that have weak or no association with the variant. It has the following 
steps: 
Step 1. Given traits ( )1, , KY YY …= , initialize r K=  and ( )rY Y= . Denote , MHT rT  as  
MHTT  based on ( )
rY . 
Step 2. Denote , iMHT rT −  as MHTT  based on ( )
rY  with the thi  trait deleted for , ,1i r= … ; 
denote , arg max ii MHT rI T −=  and , 1 , IMHT r MHT rT T −− = . Let ( )
1rY −  denote ( )rY  with 
the thI  trait deleted and update 1r r= − . 
Step 3. Repeat step 2 until 1r = . 
Denote rp  as the p-value of , MHT rT . The test statistic of MHT-O is defined as 
1    minMHT O r K rT p− ≤ ≤= . 
We use a permutation test to evaluate the p-value of MHT OT − . Intuitively, two layers 
of permutations are needed to estimate rp  and the overall p-value for the test statistic 
MHT OT − . Ge et al. [Ge et al., 2003]proposed that one layer of permutation can be used to 
estimate these p-values. We use the permutation procedure of Ge et al. to estimate rp  and 
the overall p-value for the test statistic MHT OT − . In details, we randomly shuffle the 
genotypes in each permutation. Suppose we perform B  times of permutations. Let ( ) , 
b
MHT rT  
denote the value of , MHT rT  based on the thb  permuted data, where 0b =  represents the 
original data. Then, we transfer ( ) , 
b
MHT rT  to ( )
b
rp  by 
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( )
( ) ( ){ }, , # : 0,1,for ,d bMHT r MHT r
r
b
d T T d
p
B
B> = …
= . 
Let ( ) ( )1    min
b b
r K rp p≤ ≤= , Then, the p-value of MHT OT −  is given by 
( ) (0)#{b :  for 1,2, , }b p b B
B
p = …< . 
 
The R code of MHT-O is available at Shuanglin Zhang’s homepage 
http://www.math.mtu.edu/~shuzhang/software.html. 
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Comparison of Methods 
We compare our proposed method with MHT, TATES [van der Sluis et al., 2013], 
MANOVA [Yang and Wang, 2012], and SUM_SCORE. TATES combines p-values 
obtained in a standard univariate GAWS to acquire one trait-based p-value, while 
correcting for correlations between components. SUM_SCORE performs an association 
test for each trait individually to obtain the univariate score test statistic for each trait. Then, 
the test statistic of SUM_SCORE is the summation of the univariate score test statistics. 
We use asymptotic distributions to evaluate the p-values of SUM_SCORE, TATES and 
MANOVA. 
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Simulation Studies 
To evaluate the type I error rates and powers of MHT and MHT-O, we generate genotypes 
according to minor allele frequency (MAF) and assume Hardy Weinberg equilibrium. 
Then, we generate K  traits by the factor model [van der Sluis et al., 2013; Aschard et al., 
2014] 
21fy x c cλ ε+ −+= ×γ ,                                            (1) 
where ( )1, ,
T
Ky y y= … ; x  is the genotype score at the variant of interest; ( )1, , Kλ λ λ= …  is 
the vector of effect sizes of the genetic variant on the K  traits; 
( ) ( )1 ,, ~ 0,R
Tf ff MVN…= Σ , ( )1 I Aρ ρΣ = − + , A  is a matrix with elements of 1, I  is the 
identity matrix, and ρ  is the correlation between factors; γ  is a K  by R  matrix; c  is a 
constant number; and ( )1, ,
T
Kε ε ε= …  is a vector of  residuals, and 1 ,, Kε ε…  are 
independent, and ( )~ 0,1k Nε  for , ,1k K= … . 
Based on equation (1), we consider five models: 
Model 1: There is only one factor and genotypes impact on all traits with the same effect 
size. That is, 1R = , ( ), , Tλ β β= … , and ( )1 ,1, T= …γ . 
Model 2: There are five factors and genotypes impact on one factor. That is, 5R = , 
( )0, ,0, , , Tλ β β= … … , and ( )1 2 3 4 5, , , ,diag DD D DD=γ , where ( ), ,11
T
iD …=  for ,51,i = … . 
Model 3: There are two factors and genotypes impact on one factor. That is, 2R = , 
( )0, ,0, , , Tλ β β= … … , and ( )1 2,diag D D=γ , where ( ), ,11
T
iD …=  for 1,2i = . 
Model 4: There are five factors and genotypes impact on one trait. That is, 5R = , 
( )0, ,0, Tλ β= … , and ( )1 2 3 4 5, , , ,diag DD D DD=γ , where ( ), ,11
T
iD …=  for ,51,i = … . 
Model 5: There is only one factor and genotypes impact on one trait. That is, 1R = , 
( )0, ,0, Tλ β= … , and ( )1 ,1, T= …γ . 
 To evaluate type I error rates of MHT and MHT-O, we let 0β = . To evaluate 
powers, we let 0β > . In the simulation studies for evaluation of type I error rates and 
powers, we set MAF = 0.3 and 0.2ρ = .  
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Simulation Results 
To evaluate the type I error rates of the two proposed tests (MHT and MHT-O), we consider 
20 quantitative traits. We also consider different sample sizes, different significance levels, 
and different models. In each simulation scenario, the p-values of MHT and MHT-O are 
estimated by 1,000 permutations and the type I error rates of the two tests are evaluated 
using 10,000 replicated samples. For 10,000 replicated samples, the 95% confidence 
intervals (CIs) for estimated type I error rates of nominal levels 0.05 and 0.01 are (0.046, 
0.054) and (0.008, 0.012), respectively (see end of this chapter). The estimated type I error 
rates of the two tests are summarized in Table 2.1. From this table, we can see that 58 out 
of 60 (greater than 95%) estimated type I error rates are within the 95% CIs and the two 
estimated type I error rates (0.05415 and 0.0126) not within the 95% CIs are very close to 
the bound of the corresponding 95% CI, which indicates that the two tests are all valid. 
For power comparisons, we consider different values of the effect size, different 
models, and different numbers of traits. Sample size is 1,000 for all the cases. In each of 
the simulation scenarios, the p-values of MHT and MHT-O are estimated using 1,000 
permutations and the p-values of SUM_SCORE, TATES and MANOVA are estimated 
using their asymptotic distributions. The powers of all of the five tests are evaluated using 
500 replicated samples at a significance level of 0.05. 
Figure 2.1 gives the power comparisons of the five tests (SUM_SCORE, TATES, 
MHT, MHT-O and MANOVA) for the power as a function of the effect size based on the 
five models for 20 traits. This figure shows that (1) MHT-O is either the most powerful 
one (genotypes directly impact on a single trait: models 4-5) or comparable to the most 
powerful one (genotypes directly impact on all or a portion of the traits: models 1-3) among 
the five tests; (2) MHT and MANOVA have very similar powers; (3) MHT and MANOVA 
are much less powerful than other methods when genotypes directly impact on only a 
portion of the traits (models 2-3); (4) TATES is much less powerful than other methods 
when genotypes directly impact on all the traits (model 1); and (5) SUM_SCORE is much 
less powerful than other methods when genotypes directly impact on a single trait (models 
4-5). 
Power comparisons of the five tests for 30 and 40 traits are given in Figures 2.2 and 
2.3, respectively. The patterns of power comparisons for 30 and 40 traits (Figures 2.2 and 
2.3) are similar to that for 20 traits (Figure 2.1). We also give power comparisons of the 
five tests using a significance level of 85 10−×  with 810  permutations and 500 replicates for 
20 traits under model 1 (Figure B.2.1). Figure B.2.1 shows that the patterns of the power 
comparisons using significance level 85 10−×  are similar to that using a significance level 
of 0.05 in Figure 2.1 (model 1). In summary, MHT-O is either the most powerful test or 
comparable to the most powerful test among all the tests we compared. Therefore, our 
MHT-O is a robust test to a variety of models. 
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Discussion  
We propose MHT-O to perform joint analysis of multiple traits in association studies based 
on the following reasons: (1) multiple related traits are usually measured in genetic 
association studies of complex diseases; (2) there is increasing evidence showing that 
pleiotropy is a widespread phenomenon in complex diseases; and (3) the power of existing 
methods decreases in the presence of non-associated traits. The proposed MHT-O includes 
a procedure of deleting traits that have weak or no association with the variant. Therefore, 
it can be robust to the existence and the number of non-associated traits. By deleting one 
trait that has the weakest association with the variant in each step, MHT-O can maintain 
high power in the presence of a large number of non-associated traits. This feature is 
essentially important when there exist a large number of correlated traits but there are no 
guidelines to select relevant traits. Our results show that MHT-O has correct type I error 
rates and is either the most powerful test or comparable to the most powerful test among 
the five tests we compared. No other methods in the simulation studies show consistent 
good performance. 
 Due to the allelic heterogeneity and the extreme rarity of individual variants in rare 
variant association studies, the variant-by-variant methods for common variant association 
studies may not be optimal [Li and Leal, 2008]. It has been shown by recent studies that 
complex diseases are caused by both common and rare variants [Pritchard, 2001; Pritchard 
and Cox, 2002; Walsh and King, 2007; Bodmer and Bonilla, 2008; Stratton and Rahman, 
2008; Kang et al., 2010; Teer and Mullikin, 2010]. Statistical methods including burden 
tests [Morgenthaler and Thilly, 2007; Li and Leal, 2008; Madsen and Browning, 2009; 
Price et al., 2010; Zawistowski et al., 2010], quadratic tests [Neale et al., 2011; Wu et al., 
2011; Sha et al., 2012], and combined tests [Lee et al., 2012; Derkach et al., 2013; Sha and 
Zhang, 2014] have been developed for rare variant association studies with a single trait. 
Currently, there are limited researches on rare variant association studies for joint analysis 
of multiple traits [Casale et al., 2015; Wang et al., 2015]. MHT-O can be extended to rare 
variant association studies by extending equation (1) to include multiple variants. MHT-O 
can also be extended to family-based studies by extending equation (1) to mixed linear 
model. However, the performance of MHT-O in rare variant association studies and in 
family-based association studies needs further investigation.  
The fact that population stratification can seriously confound association results has 
been long recognized in association studies based on unrelated individuals [Knowler et al., 
1988; Lander and Schork, 1994]. Several methods to control for population stratification 
have been developed for association studies based on unrelated individuals. These methods 
include principal component (PC) approach [Zhu et al., 2002; Chen et al., 2003; Zhang et 
al., 2003; Price et al., 2006; Bauchet et al., 2007], genomic control (GC) approach [Devlin 
and Roeder, 1999; Devlin et al., 2001; Reich and Goldstein, 2001], and mixed linear model 
(MLM) approach [Kang et al., 2010; Zhang et al., 2010]. Like most association tests based 
on unrelated individuals, MHT-O subjects to bias due to population stratification. To make 
MHT-O robust to population stratification, we can use the PC approach. Let 
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( )1, ,
T
i i iLP pp …=  denote the first L  PCs of the genotypes at a set of genomic markers for 
the thi  individual. Let *iky  and 
*
ix  denote the residuals of the regressions 
0
T
ik k k i ikPy α α ε++=  and the residuals of the regression 0
T
i i iPx α α ε+= + , respectively. 
Using *iky  and 
*
ix  to replace iky  and ix , we can make MHT-O robust to population 
stratification. However, the performance of using the PC approach to control for population 
stratification in MHT-O needs further investigations. 
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Confidence Interval 
Let p  denote the p-value of the test and denote a random variable 
1,
0,
p
p
ξ
α
α
≤
=  >
, 
where α  is the significance level. Then, ( )Pr 1ξ α= =  and ( )Pr 0 1ξ α= = −  because p  
follows a uniform distribution between 0 and 1 under the null hypothesis. Suppose there 
are R  replicates. Let iξ  denote the value of ξ  for the thi  replicate, where , ,1i R= … . Then, 
the estimated type I error rate is given by 
1
1 R
iiR
ξ ξ
=
= ∑  that asymptotically follows a normal 
distribution ( )1,
R
N
α α
α
 
 
−
 
. Thus,
( )
( ) ( )( ) 51.96 1P .96 1 1.96 1
1
r Pr 0.9R R
R
ξα α α α α α α
α
ξ
α
−
≤
 
  = − − ≤ ≤ +

− =
−


. 
We define ( ) ( )( )1.96 1 , 1.96 1R Rα α α α α α− − + −  as the 95% confidence 
interval for the estimated type I error rate for the nominal level α . 
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Tables and Figures 
Table 2.1. The estimated type I error rates of MHT and MHT-O. 10,000 replicates are used. 
 
    
Sample size 
 500 1000 2000 
Model 1 
𝛼𝛼 = 0.05 MHT-O 0.05415 0.0494 0.04875 
MHT 0.05235 0.05005 0.0501 
𝛼𝛼 = 0.01 MHT-O 0.01035 0.012 0.0091 
MHT 0.00985 0.01195 0.01105 
Model 2 
𝛼𝛼 = 0.05 MHT-O 0.0499 0.0515 0.0526 
MHT 0.04815 0.05175 0.05285 
𝛼𝛼 = 0.01 MHT-O 0.01045 0.01175 0.01135 
MHT 0.0117 0.0118 0.0126 
Model 3 
𝛼𝛼 = 0.05 MHT-O 0.05015 0.0517 0.05315 
MHT 0.04875 0.0507 0.0529 
𝛼𝛼 = 0.01 MHT-O 0.00995 0.0109 0.012 
MHT 0.0104 0.01035 0.012 
Model 4 
𝛼𝛼 = 0.05 MHT-O 0.04815 0.0516 0.05255 
MHT 0.04875 0.05275 0.0507 
𝛼𝛼 = 0.01 MHT-O 0.00975 0.0118 0.00975 
MHT 0.00855 0.012 0.01 
Model 5 
𝛼𝛼 = 0.05 MHT-O 0.04865 0.0499 0.04975 
MHT 0.05095 0.05195 0.04755 
𝛼𝛼 = 0.01 MHT-O 0.012 0.0119 0.00915 
MHT 0.01075 0.01115 0.0096 
30 
 
Figure 2.1. Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHT-O 
and MANOVA) for the power as a function of the effect size. Sample size is 1000. Total 
number of traits is 20.  
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Figure 2.2. Power comparisons of the five tests (SUM_ SCORE, TATES, MHT, MHT-O 
and MANOVA) for the power as a function of the effect size. Sample size is 1000. Total 
number of traits is 30.  
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Figure 2.3. Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHT-O 
and MANOVA) for the power as a function of the effect size. Sample size is 1000. Total 
number of traits is 40. 
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Chapter 3 
Testing an optimally weighted combination of common and/or rare variants with 
multiple traits 
Joint analysis of multiple traits has recently become popular since it can increase statistical 
power to detect genetic variants and there is increasing evidence showing that pleiotropy 
is a widespread phenomenon in complex diseases. Currently, most of existing methods test 
the association between multiple traits and a single common variant. However, the variant-
by-variant methods for common variant association studies may not be optimal for rare 
variant association studies due to the allelic heterogeneity as well as the extreme rarity of 
individual variants. In this article, we developed a statistical method by testing an optimally 
weighted combination of variants with multiple traits (TOWmuT) to test the association 
between multiple traits and a weighted combination of variants (rare and/or common) in a 
genomic region. TOWmuT is robust to the directions of effects of causal variants and is 
applicable to different types of traits. Using extensive simulation studies, we compared the 
performance of TOWmuT with the following five existing methods: gene association with 
multiple traits (GAMuT), multiple sequence kernel association test (MSKAT), adaptive 
weighting reverse regression (AWRR), single-TOW, and MANOVA. Our results showed 
that, in all of the simulation scenarios, TOWmuT has correct type I error rates and is 
consistently more powerful than the other five tests. We also illustrated the usefulness of 
TOWmuT by analyzing a whole-genome genotyping data from a lung function study. 
 Introduction 
 
Many large cohort studies collected many correlated traits that can reflect underlying 
mechanism of complex diseases. For example, the UK10K cohort study collected 64 
correlated phenotypic traits [The UK10K Consortium et al., 2015]. Usually complex 
diseases are characterized by multiple endophenotypes. For example, hypertension can be 
characterized by systolic and diastolic blood pressure [Newton-Cheh et al., 2009]; 
metabolic syndrome is evaluated by four component traits: high-density lipoprotein (HDL) 
cholesterol, plasma glucose and Type 2 diabetes, abdominal obesity, and diastolic blood 
pressure [Zabaneh and Balding, 2010]; and schizophrenia can be diagnosed by eight 
neurocognitive domains [Gur et al., 2007]. Multiple correlated traits can be influenced by 
a gene simultaneously. Therefore, by joint analysis of multiple traits, we can not only gain 
more statistical power to detect pleiotropic variants [Yang and Wang, 2012; Solovieff et 
al., 2013; Stephens, 2013; Zhou and Stephens, 2014; Zhu et al., 2015a; Liang et al., 2016; 
Wang et al., 2016a; Wang et al., 2016b], but also can be important to understand the genetic 
architecture of the disease of interest [Aschard et al., 2014].  
Several statistical methods have been developed for testing the association between 
multiple traits and a single common variant. These methods can be roughly divided into 
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three groups: dimension reduction methods [Klei et al., 2008; Ferreira and Purcell, 2009; 
Aschard et al., 2014; Wang et al., 2016a], regression methods [Korte et al., 2012; O'Reilly 
et al., 2012; Zhang et al., 2014], and combining test statistics from univariate analysis 
[O'Brien, 1984; Yang et al., 2010; van der Sluis et al., 2013; Kim et al., 2015; Zhu et al., 
2015b; Liang et al., 2016]. However, due to the allelic heterogeneity as well as the extreme 
rarity of rare variants [Li and Leal, 2008], the variant-by-variant methods for common 
variant association studies may not be optimal for rare variant association studies. Recent 
studies show that complex diseases are caused by both common and rare variants 
[Pritchard, 2001; Pritchard and Cox, 2002; Walsh and King, 2007; Bodmer and Bonilla, 
2008; Stratton and Rahman, 2008; Kang et al., 2010; Teer and Mullikin, 2010]. Next-
generation sequencing technology allows sequencing of the whole genome of large groups 
of individuals, and thus makes rare variant association studies feasible [Andres et al., 2007; 
Metzker, 2010]. Recently, statistical methods for rare variant association studies with a 
single trait have been developed by summarizing genotype information from multiple 
variants. These methods include burden tests [Morgenthaler and Thilly, 2007; Li and Leal, 
2008; Madsen and Browning, 2009; Price et al., 2010; Zawistowski et al., 2010], quadratic 
tests [Neale et al., 2011; Wu et al., 2011; Sha et al., 2012; Yang et al., 2017], and combined 
tests [Derkach et al., 2013; Lee et al., 2013; Sha and Zhang, 2014; Greco et al., 2015].  
As we pointed out above, it is essential to develop statistical methods to test the 
association between multiple traits and multiple variants (common and/or rare variants). 
Very recently, a few statistical methods for this purpose are appeared [Casale et al., 2015; 
Wang et al., 2015; Broadaway et al., 2016; Sun et al., 2016; Wang et al., 2016b; Wu and 
Pankow, 2016]. Casale et al. [2015] proposed a set-based association test based on the 
linear mixed-model. This method enables jointly analyzing multiple correlated traits in rare 
variant association studies while accounting for population structure and relatedness. Wang 
et al. [2015] proposed a multivariate functional linear model approach to test association 
between multiple traits and rare variants in a genomic region. In this approach, the genetic 
effects of variants are treated as smooth functions of genomic positions of these variants. 
Gene association with multiple traits (GAMuT) proposed by Broadaway et al. [2016] 
provide a nonparametric test of independence between a set of traits and a set of genetic 
variants. This method compares the similarities of multiple traits with the similarities of 
genotypes at variants in a genomic region. Multivariate Rare-Variant Association Test 
(MURAT) proposed by Sun et al. [2016] tests association between multiple correlated 
quantitative traits and a set of rare variants based on a linear mixed model. This method 
assumes that the effects of the variants follow a multivariate normal distribution with a 
zero mean and a specific covariance structure. Wu and Pankow [2016] extended the 
commonly used sequence kernel association test (SKAT) [Wu et al., 2011] for a single trait 
to multiple traits and proposed multiple sequence kernel association test (MSKAT). Wang 
et al. [2016b] proposed an adaptive weighting reverse regression (AWRR) method. This 
method uses the score test based on the reverse regression, in which the summation of 
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adaptively weighted genotypes is treated as the response variable and multiple traits are 
treated as independent variables. 
In this article, we developed a new statistical method by testing an optimally 
weighted combination of variants with multiple traits (TOWmuT) to test the association 
between multiple traits and a weighted combination of variants (rare and/or common) in a 
genomic region. TOWmuT is based on the score test under a linear model, in which the 
weighted combination of variants is treated as the response variable and multiple traits 
including covariates are treated as independent variables. The statistic of TOWmuT is the 
maximum of the score test statistic over weights. The weights at which the score test 
statistic reaches its maximum are called the optimal weights. TOWmuT is applicable to 
different types of traits and can include covariates. Using extensive simulation studies, we 
compared the performance of TOWmuT with single-TOW [Sha et al., 2012], GAMuT 
[Broadaway et al., 2016], MSKAT [Wu and Pankow, 2016], AWRR [Wang et al., 2016b] 
and MANOVA [Yang and Wang, 2012]. Our results showed that, in all the simulation 
scenarios, TOWmuT is either the most powerful test or comparable to the most powerful 
test among the six tests. We also illustrated the usefulness of TOWmuT by analyzing a real 
whole-genome genotyping data from a lung function study.  
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Methods 
We consider a sample with n  unrelated individuals. Each individual has K  potentially 
correlated quantitative or qualitative traits (1 for cases and 0 for controls for a qualitative 
trait) and has been genotyped at M variants in a genomic region. Let *iky  denote the thk  
trait value of the thi  individual and *imx  denote the genotype score of the thi  individual at 
the thm  variant, where *imx  is the number of minor alleles that the thi  individual carries at 
the thm  variant. We first centralize *iky  and *imx  as *ik ik ky yy = −  and *im im mx xx = − , where 
*
1
1 n
k i ik
y y
n =
= ∑  and *1
1 n
m imi
x x
n =
= ∑ . Let ( )1, , Ti i iKY y y= … , ( )1, , Ti i iMX x x= … , 
( )1, ,
T
nY Y Y= … , and ( )1, ,
T
nX X X= … . For the thi  individual, we consider a linear 
combination of the variants 
1
M
i m imm
x w x
=
= ∑ , where ( )1, , TMw w w= …  are weights and their 
values will be decided later.  
Without covariates  
We first describe our method without covariates. Consider the linear model 
𝑥𝑥𝑖𝑖 = 𝛽𝛽1𝑦𝑦𝑖𝑖1 + ⋯+ 𝛽𝛽𝐾𝐾𝑦𝑦𝑖𝑖𝐾𝐾 + 𝜀𝜀𝑖𝑖.                                        (1) 
The score test statistic to test the null hypothesis 𝐻𝐻0:𝛽𝛽1 = ⋯ = 𝛽𝛽𝐾𝐾 = 0 is given by  
1 2T
scoreT U V U σ
−= ,                                                  (2) 
where 
1
Tn
ii i
U x Y Y Xw
=
= =∑ , 1 T
n
ii
T
iV YY Y Y== =∑ , and 2 21
1 1n T
ii
Tx w X Xw
n n
σ
=
= =∑ . We use 
1 TA diag X X
n
 =  
 
 to replace 1 TX X
n
. Then 2σ  becomes 20 Tw Awσ =  and scoreT  becomes 
( ) ( )
1
0
T T T T
score T
w X Y Y Y Y Xw
T w
w Aw
−
= . We define the test statistic of TOWmuT as 
                                          ( )0max rTOWmuT w sco eT T w= .                                           (3)         
Let 1 2W A w= , then ( ) ( )( )10 1 2 1 2max T T Tscore mT axTOWmu WT T W A X Y Y Y Y XAλ −− −= = , where maxλ  
indicates the largest eigenvalue of a matrix. Let 0W  denote the eigenvector of 
( ) 11 2 1 2T T TA X Y Y Y Y XA−− −  corresponding to the largest eigenvalue, then 00 1 2w A W−=  is the 
optimal weights. Actually, we do not need to calculate 0w  in order to calculate TOWmuTT . If 
we let 1 TC XA X−= , then  
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( )( ) ( )( )1 11 2 1 2T T T T Tmax maTO u xWm TT A X Y Y Y Y XA Y Y Y CYλ λ− −− − == .             (4) 
We use a permutation test to evaluate the p-value of TOWmuTT . In details, we randomly 
shuffle the traits in each permutation. Note that C  and ( ) 1TY Y −  do not change in each 
permutation. Suppose that we perform B  times of permutations. Let ( )bTOWmuTT  denote the 
value of TOWmuTT  based on the thb  permuted data, where 0b =  represents the original data. 
Then, the p-value of TOWmuTT  is given by  
( ) ( ){ }0# : 1for ,,TOWmuT TOWmuTbb T T b
B
B≥ …=
.                                   (5) 
With covariates  
Assume that there are p  covariates and 1 ,,i ipz z…  denote the p  covariates of the thi  
individual. Consider the linear model 
𝑥𝑥𝑖𝑖 = 𝛼𝛼0 + 𝛼𝛼1𝑧𝑧𝑖𝑖1 + ⋯+ 𝛼𝛼𝑝𝑝𝑧𝑧𝑖𝑖𝑝𝑝 + 𝛽𝛽1𝑦𝑦𝑖𝑖1 + ⋯+ 𝛽𝛽𝐾𝐾𝑦𝑦𝑖𝑖𝐾𝐾 + 𝜀𝜀𝑖𝑖.                       (6) 
In the end of this chapter, we showed that under model (6), the score test statistic with 
covariates to test the null hypothesis 0 1: 0KH β β= = =L  is given by  
𝑇𝑇𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
𝑠𝑠 = 𝑈𝑈�𝑇𝑇𝑉𝑉�𝑈𝑈�/𝜎𝜎�2,                                                (7) 
where  𝑈𝑈� = 𝑌𝑌�𝑇𝑇𝑋𝑋�𝑤𝑤 , 𝑉𝑉� = 𝑌𝑌�𝑇𝑇𝑌𝑌� , 𝜎𝜎�2 = 1
𝑛𝑛
𝑤𝑤𝑇𝑇𝑋𝑋�𝑇𝑇𝑋𝑋�𝑤𝑤 , 𝑋𝑋� = (𝑥𝑥�𝑖𝑖𝑚𝑚) , 𝑌𝑌� = (𝑦𝑦�𝑖𝑖𝑘𝑘) , 𝑦𝑦�𝑖𝑖𝑘𝑘  and 𝑥𝑥�𝑖𝑖𝑚𝑚 
denote the residuals of iky  and imx  under 
0 1 1 ...ik k k i pk ip iky z zα α α ε= + + + +  and 0 1 1 ...im m m i pm ip imx z zα α α τ= + + + + .              (8) 
We can see the score test statistic with covariates 
o
c
escore sc rT T= .                                                      (9) 
That is, replacing iky  and imx  by their residuals 𝑦𝑦�𝑖𝑖𝑘𝑘  and 𝑥𝑥�𝑖𝑖𝑚𝑚  in the score test statistic 
without covariates scoreT , it becomes the score test statistic with covariates cscoreT . 
Therefore, we define TOWmuT statistic with covariates as 
c
TOWmuTTOWmuTT T= .                                                (10) 
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In summary, to apply TOWmuT with covariates, we adjust both trait value iky  and 
genotypic score imx  for the covariates by applying linear regressions in (8) and apply 
TOWmuT without covariates to the residuals 𝑦𝑦�𝑖𝑖𝑘𝑘 and 𝑥𝑥�𝑖𝑖𝑚𝑚. 
Comparison of Methods 
We compare the performance of our method with the following methods: Multivariate 
Analysis of Variance (MANOVA) [Liang et al., 2016], MSKAT [Wu and Pankow, 2016], 
GAMuT [Broadaway et al., 2016], AWRR [Wang et al., 2016b] and single-TOW [Sha et 
al., 2012]. Here we briefly introduce each of those methods using the notations in the 
method section. 
MANOVA: Consider a multivariate multiple linear regression model: Y X β ε= +
, where Y  denotes the n K×  matrix of phenotypes; X  denotes the n M×  matrix of 
genotypes; β  is a M K×  matrix of coefficients; ε  is the n K×  matrix of random errors 
with each row of ε  to be i.i.d. ( )0,MVN Σ , where Σ  is the covariance matrix of ε . To 
test 0 0:H β = , the likelihood ratio test is equivalent to the Wilk’s Lambda test statistic of 
MANOVA, that is, ( ) ( )( ) 00
ˆ
ˆ ˆ ˆ2 , 0, log logˆ2 log
E
E H
l l n nβ
Σ  
Λ = Σ − Σ = = −
+

Σ 
− 

 . Here 
Λ  denote the ratio of the likelihood function under 0H  to the likelihood function under 
1H , ( ),l β Σ  is the log-likelihood function, ( )ˆ ˆT TXH Xβ β=  and 
( )ˆ ˆT T TE Y Y XXβ β= − , where ( ) 1ˆ T TX X X Yβ −=  is the maximum likelihood estimator 
(MLE) of β , and  denotes the determinant of a matrix. The test statistic has an 
asymptotic 2Kχ  distribution. 
MSKAT: MSKAT extends the commonly used SKAT [Wu et al., 2011] for single 
trait analysis to test for the joint association of rare variant set with multiple continuous 
traits. 
GAMuT: GAMuT compares the similarity in multivariate phenotypes to the 
similarity in rare-variant genotypes in a genomic region by a machine-learning framework 
called kernel distance covariance. 
AWRR: by collapsing genotypes using adaptive weights, AWRR uses the score 
test to test association based on the reverse regression, in which collapsed genotypes are 
treated as the response variable and multiple traits are treated as independent variables. 
Single-TOW: Let kTOWT  denote the test statistic of TOW to test the association 
between the k th trait and the genotypes at the variants in a genomic region. The test 
39 
 
statistic of single-TOW is given by 1minsingle TOW k K kT p− ≤ ≤= , where kp  is the p-value of 
k
TOWT  for , ,1k K= … . The p-value of  single TOWT −  is estimated using a permutation 
procedure. 
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Simulations 
In our simulation studies, we use the empirical Mini-Exome genotype data provided by the 
genetic analysis workshop 17 (GAW17) to generate genotypes. This dataset contains 
genotypes of 697 unrelated individuals on 3205 genes. We choose four genes: ELAVL4 
(gene1), MSH4 (gene2), PDE4B (gene3), and ADAMTS4 (gene4) with 10, 20, 30, and 40 
variants, respectively. Then, we merge the four genes to form a super gene (Sgene) with 
100 variants. In our simulation studies, we generate genotypes based on the genotypes of 
697 individuals in the Sgene because the distribution of the minor allele frequencies 
(MAFs) in the Sgene can represent the distribution of MAFs in all of the 3205 genes [Sha 
et., 2012]. To generate a qualitative disease affection status, we use a liability threshold 
model based on a continuous phenotype (quantitative trait). An individual is defined as 
affected if the individual’s phenotype is at least one standard deviation larger than the 
phenotypic mean. This yields a prevalence of 16% for the simulated disease in the general 
population. In the following, we describe how to generate a quantitative trait. 
We consider that all causal variants are rare (MAF < 0.01). We randomly choose 
cn  rare variants as causal variants, where cn  is determined by the percentage of causal 
variants among rare variants. We use rn  and pn  to denote the number of risk rare variants 
and protective rare variants, respectively, where r p cn n n+ = . Let 
r
qix  and pjix  denote the 
genotypic scores of the thq  risk rare variant and the thj  protective rare variant for the thi  
individual, respectively. We assume that genotypes impact on L  traits. Let h  and lh  
denote the heritability of all the cn  rare causal variants for the L  traits and the thl  trait 
among the L  traits, respectively. We generate L  random numbers 1 ,, Lt t…  from a uniform 
distribution between 0 and 1. Then, the heritability of thl  trait among the L  traits is 
1
L
l l l
l
h ht t
=
= ∑ . Given the heritability of the thl  trait lh , we generate cn  random numbers 
1 ,, cnr r…  from a uniform distribution between 0 and 1. The heritability of the 
thm  causal 
variant for the thl  trait is given by ( )
1
c
m
m j
n
l l
j
h h r r
=
= ∑ . 
In our simulation studies, we consider two covariates 1Z  and 2Z , where 1Z  is a 
continuous covariate generated from a standard normal distribution, and 2Z  is a binary 
covariate taking values 0 and 1 with a probability of 0.5. We generate K  traits by 
considering the factor model [van der Sluis et al., 2013; Aschard et al., 2014; Wang et al., 
2016a] 
( ) ( )1 21 20.5 0 ,.5 , 1
T
Ky Z e c cfZ λ λ ε−… + += + + ×γ ,                           (11)                      
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where ( )1, ,
T
Ky y y= … ; ( ),11,
Te = … ; ( )1, , Kλ λ λ= …  is the vector involved genotypes; 
( ) ( )1 ,, ~ 0,R
Tf ff MVN…= Σ , ( )1 I Aρ ρΣ = − + , A  is a matrix with elements of 1, I  is the 
identity matrix, and ρ  is the correlation between if   and jf ; R  is the number of factors; 
γ  is a K  by R  matrix; c  is a constant number; ( )1, ,
T
Kε ε ε= …  is a vector of  residuals; 
and 1 ,, Kε ε…  are independent, ( )~ 0,1k Nε  for , ,1k K= … .  
We consider the following six models with different number of factors and different 
number of traits affected by genotypes. In these models, the within-factor correlation is 2c  
and the between-factor correlation is 21 cρ ρ= . 
Model 1: There is only one factor and genotypes impact on 6 traits with the same effect 
size. This is equivalent to set 1R =  and ( )1 ,1, T= …γ . In details,  
2
2 1
1 1
2
1
1 1
2
,
0
1 6
,
0.5 0.5 1
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c k
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
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
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× > −++
∑ ∑  .                (12) 
Model 2: There are five factors and genotypes impact on 6 traits. We set 5R =  and 
( )1 2 3 4 5, , , ,diag DD D DD=γ , where ( ), ,11
T
iD …=  for ,51,i = … . In details,  
( )
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2
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.             (13) 
Model 3: There are two factors and genotypes impact on 6 traits. That is, 2R =  and 
( )1 2,diag D D=γ , where ( ), ,11
T
iD …=  for 1,2i = . In details, 
( )
( ) 5
2
2
1
2
1 1 5 1
1 1 1
1
2
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0.5 0.
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f k
c kZ fc
β β ε
ε
− +  
− + 
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

+ + + × ≤ ≤= 
 + + × >
+ − −
+ −
∑ ∑
.              (14) 
Model 4: There are five factors and genotypes impact on one trait. That is, 5R =  and 
( )1 2 3 4 5, , , ,diag DD D DD=γ , where ( )1, ,1
T
iD …=  for ,51,i = … . In details, 
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Model 5: There are only two factors and genotypes impact on one trait. That is, 2R =  and 
( )1 2,diag D D=γ , where ( ), ,11
T
iD …=  for 1,2i = . In details, 
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Model 6: There is K  factors and genotypes impact on 6 traits. That is, R K= , I=γ , and 
1c = . In details, 
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Results 
To evaluate the type I error rates of the proposed test TOWmuT, we set 0kλ =  for 
, ,1k K= …  in the 6 models. We consider different sample sizes, different significance 
levels, different models, and different types of traits. In our simulations we consider 10 
traits (K = 10). In each simulation scenario, the p-values of TOWmuT are estimated by 
1000 permutations and the type I error rates of TOWmuT are evaluated using 10,000 
replicated samples. For 10,000 replicated samples, the 95% confidence intervals (CIs) for 
the estimated type I error rates of nominal levels 0.05 and 0.01 are (0.046, 0.054) and 
(0.008, 0.012), respectively. The estimated type I error rates of TOWmuT are summarized 
in Tables 3.1 and 3.2. From these two tables, we can see that 70 out of 72 (greater than 
95%) estimated type I error rates are within the 95% CIs and the two estimated type I error 
rates not within the 95% CIs (0.05555 and 0.01295) are very close to the bound of the 
corresponding 95% CI, which indicates that TOWmuT is valid. 
For power comparisons, we consider different values of heritability, different 
models, different types of traits, different percentages of protective variants, different 
values of between-factor correlation, and different values of within-factor correlation. In 
each of the simulation scenarios, the p-values of TOWmuT, AWRR and single-TOW are 
estimated using 1,000 permutations and the p-values of MANOVA, GAMuT, and MSKAT 
are estimated using asymptotic distributions. The powers of all of the six tests are evaluated 
using 1,000 replicated samples at a significance level of 0.05. 
Figure 3.1 gives the power comparisons of the six tests (Single-TOW, MSKAT, 
AWRR, MANOVA, GAMuT, and TOWmuT) for the power as a function of the total 
heritability based on the six models for 10 quantitative traits. This figure shows that (1) 
TOWmuT is consistently the most powerful one among the six tests; (2) MANOVA is the 
second most powerful when genotypes impact on multiple traits (models 1-3 and 6) while 
AWRR is the second most powerful when genotypes impact on a single trait (models 4-5); 
(3) MSKAT is consistently less powerful than other multivariate tests probably because 
SKAT gives larger weights than that of TOW to only those variants with MAF in the range 
(0.01,0.035) and there are only 8% variants with MAF in the range (0.01,0.035) in Sgene 
which our simulations are based on; and (4) MSKAT and GAMuT have similar powers in 
all six models. 
Figure 3.2 gives the power comparisons of the five tests (Single-TOW, AWRR, 
MSKAT, GAMuT, and TOWmuT) for the power as a function of the total heritability for 
the mixture of 5 quantitative traits and 5 qualitative traits. We only compare the powers of 
five tests because MANOVA has inflated type I error rate in this case. This figure shows 
that (1) TOWmuT is consistently the most powerful one among the five tests; (2) AWRR 
is second most powerful when genotypes impact on multiple traits (models 1-3 and 6) while 
MSKAT and GAMuT are second most powerful when genotypes impact on a single trait 
(models 4-5); (3) MSKAT and GAMuT have similar powers in all six models; and (4) 
single-TOW is consistently less powerful than other four multivariate tests because we 
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keep correlations between traits similar to that in Figure 3.1 such that correlations between 
original quantitative traits are larger than that in Figure 3.1.  
We also compare the powers of the six tests for the power as a function of the 
within-factor correlation for models 1-5 and between-factor correlation for model 6 for 10 
quantitative traits (Figure B.3.1). As shown in this figure, the power of single-TOW is 
robust to the between-factor correlation or the within-factor correlation since the minimum 
p-value-based approach is largely unaffected by the trait correlation (Wu and Pankow 
2016). However, with the increasing of the between-factor correlation or within-factor 
correlation, the power of other five tests essentially increases. Other patterns of the power 
comparisons are similar to those of in Figure B.3.1. 
Power comparisons of the six tests for the power as a function of the percentage of 
protective variants for 10 quantitative traits are given by Figure B.3.2. This figure shows 
that the power of all six tests are robust to the percentage of protective variants, therefore, 
all of these methods are robust to the directions of the genetic effects. Other patterns of the 
power comparisons are similar to those of in Figure 3.1. 
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Application to the COPDGene 
Chronic obstructive pulmonary disease (COPD) is a common disease in elderly patients 
that causes significant morbidity and mortality [Nazir and Erbland, 2009]. The Genetic 
Epidemiology of COPD Study (COPDGene) [Regan et al., 2010] was designed to identify 
genetic factors associated with COPD. In this COPDGene study, a total of more than 
10,000 subjects have been enrolled including 2/3 non-Hispanic Whites (NHW) and 1/3 
African-Americans (AA). In this analysis, we only include 5,430 NHW with no missing 
phenotypes. Each of the 5,430 NHW has been genotyped at 630,860 SNPs. Based on the 
literature studies of COPD [Han et al., 2011; Chu et al., 2014; Liang et al., 2016], we 
selected 7 key quantitative COPD-related phenotypes, including FEV1 (% predicted 
FEV1), Emphysema (Emph), Emphysema Distribution (EmphDist), Gas Trapping 
(GasTrap), Airway Wall Area (Pi10), Exacerbation frequency (ExacerFreq), Six-minute 
walk distance (6MWD), and 4 covariates, including BMI, Age, Pack-Years (PackYear) 
and Sex.  
To evaluate the performance of our proposed method on a real data set, we applied 
six methods (TOWmuT, MANOVA, MSKAT, GAMuT, AWRR, and single-TOW) to the 
COPDGene of NHW population to test the association between each of 50-SNP blocks and 
the 7 key quantitative COPD-related phenotypes. To identify significant 50-SNP blocks 
associated with the phenotypes, we used Bonferroni correction to decide the significance 
level. The total number of 50-SNP blocks is 12617, therefore, the Bonferroni corrected 
significance level is 0.05/12617 ≈ 4×10-6. Table 3.3 summarized the significant blocks 
identified by at least one method. There were total six significant blocks in Table 3. All of 
the six blocks have been previously reported to be in association with COPD or lung 
functions [Pillai et al., 2009; Cho et al., 2010; Figarska et al., 2014; Lutz et al., 2015]. 
PDSS1 and ABI1 are located between LOC107984176 and LOC105376467, which are 
Intergenic regions and contain the SNPs associated with pulmonary function [Imboden et 
al., 2012; Lutz et al., 2015]. From Table 3, we can see that TOWmuT identified four blocks; 
AWRR identified two blocks; MANOVA, MSKAT and GAMuT identified one block; 
single-TOW did not identify any blocks. From these results, we can see that TOWmuT 
identified the most of significant 50-SNP blocks among the six methods, which is 
consistent with the results of our simulation studies. 
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Discussion 
We developed TOWmuT to perform joint analysis of multiple traits in gene-based 
association studies based on the following reasons: (1) multiple related traits are usually 
measured in genetic association studies of complex diseases; (2) there is increasing 
evidence showing that pleiotropy is a widespread phenomenon in complex diseases; and 
(3) there is a shortage of gene-based approaches for multiple traits. We used extensive 
simulation studies to compare the performance of TOWmuT with MANOVA, MSKAT, 
AWRR, GAMuT and Single-TOW. Our results showed that TOWmuT has correct type I 
error rates and is consistently more powerful than other five methods. Additionally, the 
real data analysis results demonstrated that the proposed method has great potential in 
gene-based association study for complex diseases with multiple phenotypes such as 
COPD. 
Recently, it has become a major focus of investigation to identify a small number 
of rare causal variants that contribute to complex diseases [Capanu and Ionita-Laza, 2015]. 
Several methods to pinpoint the causal variants have been developed for testing the 
association with a single trait. These methods include backward elimination (BE) method 
[Ionita-Laza et al., 2014], hierarchical model method [Ionita-Laza et al., 2014], and 
adaptive combination of p-values method [Lin, 2016]. To extend the TOWmuT method to 
identify a small number of causal variants which are associated with multiple traits, we can 
use the BE method. In each step, we remove one variant that has the smallest contribution 
to the association between multiple traits and the set of variants and then we evaluate the 
p-value for testing association between multiple traits and the remaining variants by 
TOWmuT. Causal variants are the set of variants corresponding to the smallest p-value. 
The computation time required for running TOWmuT depends on the sample size, 
the number of variants in the genomic region, the number of traits, and the number of 
permutations. The running time of TOWmuT with 1000 permutations on a data set with 
5000 individuals, 7 traits and 10 variants in a genomic region on a laptop with 4 Intel Cores 
@ 3.30GHz and 4 GB memory is about 0.14s. To perform genome-wide association 
studies, we can first select genomic regions that show evidence of association based on a 
small number of permutations (e.g. 1,000), and then a large number of permutations are 
used to test the selected regions. 
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Tables and Figures 
Table 3.1. The estimated type I error rates of TOWmuT for 10 quantitative traits under 
each model with covariates. 
 
 Sample Size 
Model 500 1000 2000 
α = 0.05 1 0.05365 0.0515 0.0515 
2 0.0521 0.0528 0.0504 
3 0.0513 0.0540 0.0503 
4 0.0514 0.0511 0.05 
5 0.05381 0.04825 0.05 
6 0.0482 0.0508 0.05325 
α = 0.01 1 0.01165 0.0098 0.0117 
2 0.012 0.01015 0.0102 
3 0.01175 0.01075 0.0113 
4 0.01145 0.01075 0.0118 
5 0.01141 0.01095 0.0117 
6 0.0097 0.0105 0.01185 
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Table 3.2. The estimated type I error rates of TOWmuT for the mixture of five quantitative 
traits and five qualitative traits under each model with covariates. 
 
 Sample Size 
Model 500 1000 2000 
α = 0.05 1 0.05365 0.05385 0.05005 
2 0.0511 0.0483 0.05115 
3 0.0508 0.05375 0.052 
4 0.0529 0.04915 0.0536 
5 0.054 0.05355 0.04825 
6 0.05555 0.0493 0.0529 
α = 0.01 1 0.0105 0.01295 0.00995 
2 0.0105 0.009 0.0097 
3 0.01145 0.0104 0.0101 
4 0.01065 0.00945 0.01165 
5 0.0118 0.0105 0.00875 
6 0.01195 0.00935 0.01105 
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Table 3.3. Significant blocks identified by at least one method (p-values less than 4×10-6) 
and the corresponding p-values in the analysis of COPDGene. 
 
 
 
  
CHR POS1 POS2 Genes TOWmuT MANOVA MSKAT GAMuT AWRR 
Single-
TOW 
2 
17800098
5 
1784191
17 
NFE2L2 0.20883 2.62E-06 0.02508 0.02505 0.25796 
0.1546
8 
4 
14527883
7 
1456970
40 
HHIP 1.00E-07 7.71E-06 0.03992 0.03984 0 
0.0008
5 
10 26908475 
2715009
3 
PDSS1, 
ABI1  
4.00E-06 0.04050 0.01242 0.01247 1.6E-05 
0.0284
5 
15 78593362 
7882591
7 
IREB2, 
AGPHD1 
1.00E-07 0.00191 0.70349 0.70357 5.6E-06 
0.2348
4 
15 78826180 
7900644
2 
PSMA4, 
CHRNA5, 
CHRNA3, 
CHRNB4 
2.90E-06 0.00037 0.06255 0.06252 0 
0.3764
3 
15 79006582 
7926781
7 
ADAMTS
7 
9.01E-05 4.78E-05 2.25E-06 6.42E-07 0.04849 
0.0195
3 
50 
 
 
Figure 3.1. Power comparisons of the six tests (Single-TOW, MSKAT, AWRR, 
MANOVA, GAMuT and TOWmuT) for the power as a function of total heritability for 10 
quantitative traits with covariates. The sample size is 1000. The between-factor correlation 
is 0.3 and the within-factor correlation is 0.7. The percentage of the causal variants is 0.2. 
All causal variants are risk variants. 
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Figure 3.2. Power comparisons of the five tests (Single-TOW, AWRR, GAMuT, MSKAT 
and TOWmuT) for the power as a function of heritability for the mixture of half 
quantitative traits and half qualitative traits with covariates. The sample size is 1000. 
Covariance matrix of 10 traits is similar to that of 10 quantitative traits with between-factor 
correlation being 0.3 and the within-factor correlation being 0.7. The percentage of the 
causal variants is 0.2. All causal variants are risk variants. 
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Appendix A: Supplementary Tables 
Table A.1.1. The estimated type I error rates of four methods for quantitative traits and 
variance model 2. We use 10,000 replicates. This set of simulations is based on Sgene1.   
 
 Sample size 
 500 1000 2000 
𝛼𝛼 = 0.05 CCA 0.049 0.05165 0.05505 
Single-TOW 0.05055 0.05325 0.05345 
WSRR 0.0472 0.0488 0.0505 
AWRR 0.0534 0.054 0.0502 
𝛼𝛼 = 0.01 CCA 0.0099 0.0116 0.0115 
Single-TOW 0.01125 0.0118 0.012 
WSRR 0.0086 0.0084 0.0103 
AWRR 0.0107 0.0114 0.0104 
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Table A.1.2. The estimated type I error rates of four methods for qualitative traits and 
variance model 2. We use 10,000 replicates. This set of simulations is based on Sgene1. 
 
 Sample size 
 500 1000 2000 
𝛼𝛼 = 0.05 CCA 0.0473 0.05225 0.0539 
Single-TOW 0.0521 0.0559 0.0508 
WSRR 0.0485 0.0493 0.0522 
AWRR 0.0469 0.0493 0.05235 
𝛼𝛼 = 0.01 CCA 0.00975 0.0106 0.012 
Single-TOW 0.00975 0.01045 0.00955 
WSRR 0.0093 0.0109 0.0106 
AWRR 0.01115 0.0104 0.012 
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Appendix B: Supplementary Figures 
Figure B.1.1. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for quantitative traits and variance model 
2. The sample size is 1000 and 0.5ρ = . The percentage of the causal variants is 0.1. All 
causal variants are risk variants. The total number of traits is 10. This set of simulations is 
based on Sgene1.  
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Figure B.1.2. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for quantitative traits 
and variance model 2. The sample size is 1000, the percentage of causal variants is 0.2, the 
total heritability is 0.03, and 0.5ρ = . The total number of traits is 10. This set of 
simulations is based on Sgene1.  
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Figure B.1.3. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for quantitative traits 
and variance model 2. The sample size is 1000, 0.5ρ = , and the total heritability is 0.03. 
All causal variants are risk variants. The total number of traits is 10. This set of simulations 
is based on Sgene1. 
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Figure B.1.4. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for qualitative traits and variance model 
1. The sample size is 1000 and 0.5ρ =  . The percentage of the causal variants is 0.1. All 
causal variants are risk variants. The total number of traits is 10. This set of simulations is 
based on Sgene1.  
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Figure B.1.5. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for qualitative traits 
and variance model 1. The sample size is 1000, the percentage of causal variants is 0.2, the 
total heritability is 0.03, and 0.5ρ =  . The total number of traits is 10. This set of 
simulations is based on Sgene1. 
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Figure B.1.6. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for qualitative traits 
and variance model 1. The sample size is 1000, 0.5ρ = , and the total heritability is 0.03. 
All causal variants are risk variants. The total number of traits is 10. This set of simulations 
is based on Sgene1. 
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Figure B.1.7. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for qualitative traits and variance model 
2. The sample size is 1000 and   . The percentage of the causal variants is 0.1. All causal 
variants are risk variants. The total number of traits is 10. This set of simulations is based 
on Sgene1. 
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Figure B.1.8. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for qualitative traits 
and variance model 2. The sample size is 1000, the percentage of causal variants is 0.2, the 
total heritability is 0.03, and 0.5ρ = . The total number of traits is 10. This set of 
simulations is based on Sgene1. 
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Figure B.1.9. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for qualitative traits 
and variance model 2. The sample size is 1000, 0.5ρ = , and the total heritability is 0.02. 
All causal variants are risk variants. The total number of traits is 10. This set of simulations 
is based on Sgene1. 
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Figure B.1.10. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of heritability for quantitative traits under variance 
model 1. The sample size is 1000 and 0.5ρ = . The percentage of the causal variants is 0.1. 
All causal variants are risk variants. This set of simulations is based on Sgene2 
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Figure B.1.11. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of percentage of protective variants for quantitative traits 
under variance model 1. The sample size is 1000, the percentage of causal variants is 0.2, 
the total heritability is 0.03, and 0.5ρ = . This set of simulations is based on Sgene2.  
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Figure B.1.12. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of the percentage of causal variants for quantitative traits 
under variance model 1. The sample size is 1000 and 0.5ρ = , and the total heritability is 
0.03. All causal variants are risk variants. The total number of traits is 10. This set of 
simulations is based on Sgene2. 
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Figure B.1.13. Power comparisons of the four tests (WSRR, AWRR, CCA and Single-
TOW) for the power as a function of LP for quantitative traits under variance model 1. LP 
represents the number of traits positively correlated with risk variants. The sample size is 
1000 and the total heritability is 0.015. All causal variants are risk variants. The total 
number of traits is 10. This set of simulations is based on Sgene2. 
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Figure B.2.1. Power comparisons of the five tests (SUM_SCORE, TATES, MHT, MHT-
O and MANOVA) for the power as a function of the effect size (model 1). Sample size is 
1000. Total number of traits is 20. The significance level is 85 10−× . The number of 
replicates is 500. The number of permutations is 810 . 
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Figure B.3.1. Power comparisons of the six tests (Single-TOW, MSKAT, AWRR, 
MANOVA, GAMuT and TOWmuT) for the power as a function of within-factor 
correlation for models 1-5 and between-factor correlation for model 6 for 10 quantitative 
traits with covariates. The sample size is 1000. The percentage of the causal variants is 
0.2. All causal variants are risk variants and  is for models 1-5. Heritabilities for 
models 1-6 are 0.05, 0.09, 0.08, 0.03, 0.03, and 0.06, respectively. 
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Figure B.3.1. Power comparisons of the six tests (Single-TOW, MSKAT, AWRR, 
MANOVA, GAMuT and TOWmuT) for the power as a function of the percentage of 
protective variants for 10 quantitative traits with covariates. The sample size is 1000. The 
percentage of the causal variants is 0.2. The between-factor correlation is 0.3 and the 
within-factor correlation is 0.7. 
 
